CFC Rejects Yet Another Government Argument to Extend CDA Statute of Limitations
Client Alert | 1 min read | 08.15.12
In yet another recent CDA statute of limitations decision, the Court of Federal Claims in Raytheon Company v. United States (July 26, 2012) denied the government's motion for reconsideration of its April 2012 decision holding that the CO's final decision was barred by the six-year SOL. In its motion, the government argued that it was entitled by FAR 31.201-2 to complete an audit before the SOL could begin to run, but the CFC rejected that argument, holding that "the statute of limitations begins to run when information that equates to knowledge of a potential claim becomes available to the Government" and that under this standard the government was "on notice" of a potential claim against the contractor based on information it obtained when it entered into an advance agreement with Raytheon in 1999 about the costs at issue.
Contacts
Insights
Client Alert | 7 min read | 06.26.26
Federal Roundup: Updates for PBMs and Medicare Advantage Organizations
In June 2026, federal regulators and lawmakers continued their efforts to improve drug affordability through targeted reforms. These recent developments will primarily impact pharmaceutical manufacturers, managed care organizations, and pharmacy benefit managers (PBM) serving Medicare Part D program members. PBMs, Medicare Advantage organizations, and Part D sponsors should monitor these changes in the interest of maintaining compliance and providing input on regulatory proposals that may influence their business operations or compensation structures in the future.
Client Alert | 6 min read | 06.26.26
Client Alert | 4 min read | 06.25.26
Twin Executive Orders Seek to Spur Quantum Leap in Technology and Cybersecurity
Client Alert | 7 min read | 06.24.26
